Lumida
/UTMD
⌘K
Utah Medical Products Inc

Utah Medical Products Inc

UTMD
$69.80USD-2.70%-1.94 today

MARKET CAP

222.2M

P/E (TTM)

20.7x

FWD P/E

DAY RANGE

$69 – $71

52W RANGE

$54
$76

AI Summary

Stalk
StalkMedium

UTMD remains in a Stage 2 advancing regime supported by higher highs and higher lows, but price is encountering resistance at the July highs under overbought conditions. Short-term EMAs have flattened and price is holding just above them, reducing immediate upside edge. We will defer new entries and wait for pullbacks into the rising 9-/21-EMA zone, with the 50-DMA providing structural support.

  • Quarterly dividend of $0.31 (+1.6% YoY) yields ~0.57%
  • Earnings yield ~25% indicates attractive valuation vs peers
  • Growth score is negative, suggesting weak expansion potential
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Utah Medical Products, Inc. (NASDAQ: UTMD) is a leading manufacturer of medical devices focused on providing innovative solutions primarily for the global healthcare market. The company specializes in the development of products related to obstetrics, gynecology, and cardiology, solidifying its competitive position within the healthcare devices sector. As a significant player in this niche, Utah Medical aligns with the broader theme of advancing medical technologies and improving patient care outcomes, leveraging its established market presence and commitment to quality.

Bull says

  • Quarterly dividend of $0.31 (+1.6% YoY) yields ~0.57%
  • Earnings yield ~25% indicates attractive valuation vs peers
  • Low leverage reflects manageable debt and reduced financial risk
  • Profitability metrics show solid revenue-to-profit conversion
  • Specialized obstetrics and cardiology focus ensures niche demand
  • Aging demographics and rising healthcare spend support growth

Bear says

  • Growth score is negative, suggesting weak expansion potential
  • Stock fell 5.6%, breaking key moving averages near $65.53
  • Low institutional ownership dampens upside momentum
  • Negative liquidity score may hinder capital-raising efforts
  • Weak momentum and revisions scores heighten downside risk
  • Competition and tech advances pose disruption threats

Investment themes with UTMD

Health Care Equipment & Supplies +0.40%

Clinical instruments and devices powering patient care

ABT · ISRG · SYK